Skip to content

Welcome to Discover Pharma! Today is : November 8, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Digital & Data

  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Elsevier launches Reaxys AI Search to support faster chemical discovery and interdisciplinary R&D

    New natural language capability aims to reduce barriers for researchers [...]

    May 5, 2026
  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    Latent Labs unveils AI model Latent-X for instant, lab-validated protein binder design

    No-code platform opens early access to generative binder design with [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Briya launches clinical-grade AI assistant for accelerating medical and epidemiological research

    New AI platform designed to support faster discovery, better study [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Medical devices,Opinion & Events

    Magentiq Eye secures Series A funding to advance AI-powered colonoscopy solutions

    Investment led by aMoon will support US and EU commercialisation [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    Nearly three-quarters of scientists expect a recession – but most still plan to spend LINUS survey reveals

    Despite political and economic pressures, researchers remain focused on collaboration, [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    OMNY Health dataset surpasses 100M patients, creating largest US repository of unstructured clinical data

    OMNY Health has reached a major milestone, announcing that its [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    Labguru and Titian Software rebrand as Cenevo to accelerate scientific discovery

    Labguru and Titian Software have rebranded under a unified identity, [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    Retab launches developer-first document AI platform and raises $3.5M in pre-seed funding

    Retab, a startup aiming to simplify document automation for developers, [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Linus Health unveils AI-powered advances in early Alzheimer’s detection and personalized brain health at AAIC 2025

    Digital assessments designed to support earlier diagnosis, streamline Alzheimer’s trial [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    AI-powered bioreactor project aims to transform biologics manufacturing

    A Canada–UK collaboration is developing an AI-driven bioreactor platform designed [...]

    May 5, 2026
Previous252627Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Biogen’s felzartamab approved in China for multiple myeloma
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics
  • Agenus reports deep responses with immunotherapy in Phase 2 colon cancer study
    Categories: Advanced Therapies, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • CEPI funds Minapharm’s Phase 1 Bundibugyo Ebola vaccine programme
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top